|
Kratom (Mitragyna speciosa): The Plant, Its Alkaloids and What Research Shows About How It Works
|
|
0
|
19
|
October 14, 2026
|
|
Kratom Risks: What the Death Reports Show, Liver Injury, Dependence and Withdrawal (Part 1 of 2)
|
|
0
|
11
|
October 14, 2026
|
|
Terpenes in Cannabis: What They Are, How Much Survives Drying, and Which Effect Claims the Evidence Supports
|
|
0
|
21
|
October 16, 2026
|
|
Six Conditions With One Paragraph Each: Psoriasis, Itching, Herpes, Sickle Cell Disease, Leukaemia and MRSA
|
|
0
|
11
|
October 16, 2026
|
|
Cannabis and Spinal Cord Injury: Rat Recovery, Human Spasticity, and the Difference Between the Two
|
|
0
|
7
|
October 16, 2026
|
|
Clinical Endocannabinoid Deficiency: A Hypothesis Worth Understanding, and Why It Is Not a Diagnosis
|
|
0
|
7
|
October 16, 2026
|
|
Cannabis in ALS and Huntington's Disease: One Encouraging Trial, One Failed Trial, and a Case Story That Proves Nothing
|
|
0
|
6
|
October 16, 2026
|
|
Cannabis as an Antibacterial: A Line of Research That Started in the 1950s, Was Confirmed in 2008, and Still Has No Product
|
|
0
|
9
|
October 16, 2026
|
|
The Dead Monkey Study: How One Unreplicated Experiment from the 1970s Shaped Beliefs About Cannabis and the Brain, and the Jamaica Study That Mirrors It
|
|
0
|
11
|
October 16, 2026
|
|
Cannabinoids and Glioma: A Real University Laboratory, a Real Finding, and Why Brain Tumour Patients Should Still Not Read It as Hope
|
|
0
|
6
|
October 15, 2026
|
|
Cannabis and the Lungs: A Genuine Bronchodilator Delivered by the Worst Possible Route
|
|
0
|
7
|
October 15, 2026
|
|
Chemotherapy-Induced Nausea and Vomiting: The Indication That Made Cannabinoids a Licensed Medicine — and Where It Stands Now
|
|
0
|
13
|
October 15, 2026
|
|
Cannabis, Appetite Loss and Cachexia: The Indication Everyone Assumes Is Proven, and What the Trials Found Instead
|
|
0
|
13
|
October 15, 2026
|
|
Cannabis as Substitution for Alcohol and Opioids: A Real Harm-Reduction Question Resting on Almost No Evidence
|
|
0
|
8
|
October 15, 2026
|
|
Cannabis, Diabetes and Bone Density: What the Human Data Actually Show
|
|
0
|
6
|
October 15, 2026
|
|
Cannabis in HIV and Hepatitis C: Where the Evidence Holds, and Where the Treatment Landscape Moved On Without It
|
|
0
|
6
|
October 15, 2026
|
|
Cannabis and the Heart: The Blood-Pressure Claim, the Stroke Studies, and the 2024–2025 Human Data That Changed the Balance
|
|
0
|
8
|
October 15, 2026
|
|
Cannabis and Autoimmune Disease: Rheumatoid Arthritis and Inflammatory Bowel Disease — Symptoms Improve, Inflammation Does Not
|
|
0
|
8
|
October 15, 2026
|
|
Cannabis and Neurodevelopmental Conditions in Children: ADHD, Autism and Tourette Syndrome — What the Trials Show and What They Cannot
|
|
0
|
8
|
October 15, 2026
|
|
Cannabis and PTSD: A Strong Argument From 2012, and What the First Randomised Trial Actually Found
|
|
0
|
13
|
October 15, 2026
|
|
Cannabis, Depression and Bipolar Disorder: Why the Dose-Response Curve Matters
|
|
0
|
13
|
October 15, 2026
|
|
Cannabis and Multiple Sclerosis: The Strongest Evidence in the Field — and the Uncomfortable Split Inside It
|
|
0
|
10
|
October 15, 2026
|
|
Cannabinoid Pharmacokinetics: Why the Same Dose Behaves Like Two Different Drugs Depending on How It Enters the Body
|
|
0
|
13
|
October 15, 2026
|
|
Why Personal Testimony Is Not Medical Evidence — and What It Is Good For Instead
|
|
0
|
9
|
October 15, 2026
|
|
Approved Cannabinoid Medicines: Nabiximols, Dronabinol and Nabilone
|
|
0
|
8
|
October 14, 2026
|
|
Cannabis for Migraine and Cluster Headache
|
|
0
|
5
|
October 14, 2026
|
|
Cannabis, Pregnancy and Breastfeeding: What the Evidence Says
|
|
0
|
9
|
October 14, 2026
|
|
Cannabis, Anxiety, and PTSD: Evidence and Limits
|
|
0
|
11
|
October 14, 2026
|
|
The Entourage Effect: Evidence vs. Marketing
|
|
0
|
11
|
October 14, 2026
|
|
Cannabis and Glaucoma: The Effect Is Real, and That Is Exactly Why Eye Doctors Say No
|
|
0
|
7
|
October 14, 2026
|